Related Experiment Video

Updated: Jul 9, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Development of in vitro methods to predict induction of CYP1A2 and CYP3A4 in humans

G Scott Grover1, Timothy G Brayman, Richard L Voorman

  • 1Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and Development, Ann Arbor, MI, USA. scott.grover@pfizer.com

Assay and Drug Development Technologies
|December 7, 2007
PubMed

Insights

The aryl hydrocarbon receptor (AHR) and pregnane X receptor (PXR) are key drivers of drug-drug interactions. This study presents in vitro methods to detect AHR- and PXR-mediated induction of CYP1A2 and CYP3A4 enzymes.

Area of Science:

  • Pharmacology and Toxicology
  • Drug Metabolism and Pharmacokinetics (DMPK)

Background:

  • Cytochrome P450 (CYP) drug-metabolizing enzymes play a crucial role in drug efficacy and safety.
  • Enzyme induction by drugs can lead to significant drug-drug interactions (DDIs).
  • The aryl hydrocarbon receptor (AHR) and pregnane X receptor (PXR) are increasingly recognized as primary mediators of clinically relevant DDIs.

Purpose of the Study:

  • To investigate the role of AHR and PXR in drug-metabolizing enzyme induction.
  • To present in vitro methods for detecting AHR- and PXR-mediated induction of key drug-metabolizing enzymes.
  • To identify reliable biomarkers for assessing potential drug induction liabilities.

Main Methods:

  • Utilized several in vitro assays to detect AHR- and PXR-mediated induction.
  • Employed fresh and cryopreserved primary human hepatocytes for testing.
  • Included stable transfectants and transiently transfected immortalized cell lines.

Main Results:

  • CYP1A2 and CYP3A4 were identified as reliable biomarkers for AHR and PXR induction, respectively.
  • Demonstrated the capability of the presented in vitro methods to detect induction liabilities.
  • Validated the role of AHR and PXR in modulating drug-metabolizing enzyme activity.

Conclusions:

  • AHR and PXR are critical regulators of drug-metabolizing enzymes and transporters.
  • CYP1A2 and CYP3A4 serve as effective biomarkers for AHR and PXR activation.
  • The developed in vitro methods are valuable tools for predicting drug-induced DDIs.

More Related Videos

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality10:56

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Published on: May 5, 2022

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...